Summary
This NIH funding opportunity (PAR-25-336) solicits R01 research grant applications focused on translating nanotechnology-based cancer interventions toward clinical or practical application. Clinical trials are explicitly not allowed under this mechanism. The program is issued by the National Institutes of Health under the Department of Health and Human Services and runs through November 2027, indicating a multi-cycle, standing announcement accepting applications on a rolling basis.
